NCT05878977View on ClinicalTrials.gov

Biomarkers in Immunotherapy of Melanoma

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)Exosomal mRNA Expression of PD-L1 and IFNγ
Interventions
DRUG

Immune checkpoint inhibitor

Identification of novel predictive and prognostic biomarkers for immunotherapy treatment response in metastatic melanoma

Trial Locations (1)

Unknown

RECRUITING

Institute of Oncology Ljubljana, Ljubljana

All Listed Sponsors
collaborator

Blood Transfusion Centre of Slovenia

OTHER_GOV

collaborator

University Medical Centre Ljubljana

OTHER

collaborator

University of Ljubljana

OTHER

lead

Institute of Oncology Ljubljana

OTHER